RESUMEN
BACKGROUND: PAI-1 gain-of-function variants promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma. OBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway obstruction is modified by asthma status, and whether any genotype effect persists after accounting for common exposures that increase PAI-1 level. METHODS: We studied 2070 Latino children (8-21y) with genotypic and pulmonary function data from the GALA II cohort. We estimated the relationship of the PAI-1 risk allele with FEV1/FVC by multivariate linear regression, stratified by asthma status. We examined the association of the polymorphism with asthma and airway obstruction within asthmatics via multivariate logistic regression. We replicated associations in the SAPPHIRE cohort of African Americans (n=1056). Secondary analysis included the effect of the at-risk polymorphism on postbronchodilator lung function. RESULTS: There was an interaction between asthma status and the PAI-1 polymorphism on FEV1 /FVC (P=.03). The gain-of-function variants, genotypes (AA/AG), were associated with lower FEV1 /FVC in subjects with asthma (ß=-1.25, CI: -2.14,-0.35, P=.006), but not in controls. Subjects with asthma and the AA/AG genotypes had a 5% decrease in FEV1 /FVC (P<.001). In asthmatics, the risk genotype (AA/AG) was associated with a 39% increase in risk of clinically relevant airway obstruction (OR=1.39, CI: 1.01, 1.92, P=.04). These associations persisted after exclusion of factors that increase PAI-1 including tobacco exposure and obesity. CONCLUSIONS AND CLINICAL RELEVANCE: The decrease in the FEV1 /FVC ratio associated with the risk genotype was modified by asthma status. The genotype increased the odds of airway obstruction by 75% within asthmatics only. As exposures known to increase PAI-1 levels did not mitigate this association, PAI-1 may contribute to airway obstruction in the context of chronic asthmatic airway inflammation.
Asunto(s)
Obstrucción de las Vías Aéreas/genética , Obstrucción de las Vías Aéreas/metabolismo , Mutación con Ganancia de Función , Inhibidor 1 de Activador Plasminogénico/genética , Inhibidor 1 de Activador Plasminogénico/metabolismo , Adolescente , Adulto , Obstrucción de las Vías Aéreas/epidemiología , Obstrucción de las Vías Aéreas/fisiopatología , Alelos , Asma Ocupacional/epidemiología , Asma Ocupacional/genética , Asma Ocupacional/metabolismo , Asma Ocupacional/fisiopatología , Niño , Estudios de Cohortes , Etnicidad , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Oportunidad Relativa , Polimorfismo de Nucleótido Simple , Pruebas de Función Respiratoria , Adulto JovenRESUMEN
Phaeosphaeriaceae is a family in the order Pleosporales containing numerous plant pathogens, endophytes, lichenised fungi, and environmental saprobes. A novel genus, Tintelnotia is introduced containing two species, one of which caused an eye infection and several nail infections in humans. All species of Tintelnotia produce conidia in soft pycnidia with a wide ostiole. The generic type species is T. opuntiae causing necrotic spots on cactus plants. The isolates of the human opportunist T. destructans showed variable susceptibility pattern to a panel of common antifungal agents. The MICs of amphotericin B, voriconazole, posaconazole and itraconazole were 1 µg/mL, complemented by an in vitro MEC of 16 µg/mL against caspofungin; the MIC of terbinafine was 0.125 µg/mL. The latter compound contributed to the successful therapy in the ocular mycosis refractory to standard antifungal therapy, the benefit of terbinafine should be highlighted as a therapeutic option especially in difficult-to-treat fungal keratitis.
Asunto(s)
Ascomicetos/efectos de los fármacos , Ascomicetos/aislamiento & purificación , Córnea/microbiología , Infecciones Fúngicas del Ojo/microbiología , Uñas/microbiología , Anfotericina B/farmacología , Antifúngicos/farmacología , Ascomicetos/clasificación , Ascomicetos/genética , Caspofungina , Equinocandinas/farmacología , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Femenino , Humanos , Itraconazol/farmacología , Queratitis/tratamiento farmacológico , Lipopéptidos/farmacología , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Naftalenos/farmacología , Naftalenos/uso terapéutico , Filogenia , Terbinafina , Triazoles/farmacología , Voriconazol/farmacologíaRESUMEN
BACKGROUND: Younger maternal age at birth is associated with increased risk of asthma in offspring in European descent populations, but has not been studied in Latino populations. OBJECTIVES: We sought to examine the relationship between maternal age at birth and prevalence of asthma in a nationwide study of Latino children. METHODS: We included 3473 Latino children aged 8-21 years (1696 subjects with physician-diagnosed asthma and 1777 healthy controls) from five US centres and Puerto Rico recruited from July 2008 through November 2011. We used multiple logistic regression models to examine the effect of maternal age at birth on asthma in offspring overall and in analyses stratified by ethnic subgroup (Mexican American, Puerto Rican and other Latino). Secondary analyses evaluated the effects of siblings, acculturation and income on this relationship. RESULTS: Maternal age < 20 years was significantly associated with decreased odds of asthma in offspring, independent of other risk factors (OR = 0.73, 95% CI: 0.57-0.93). In subgroup analyses, the protective effect of younger maternal age was observed only in Mexican Americans (OR = 0.53, 95% CI: 0.36, 0.79). In Puerto Ricans, older maternal age was associated with decreased odds of asthma (OR = 0.65, 95% CI: 0.44-0.97). In further stratified models, the protective effect of younger maternal age in Mexican Americans was seen only in children without older siblings (OR = 0.44, 95% CI: 0.23-0.81). CONCLUSION AND CLINICAL RELEVANCE: In contrast to European descent populations, younger maternal age was associated with decreased odds of asthma in offspring in Mexican American women. Asthma is common in urban minority populations but the factors underlying the varying prevalence among different Latino ethnicities in the United States is not well understood. Maternal age represents one factor that may help to explain this variability.
Asunto(s)
Asma/epidemiología , Asma/etiología , Hispánicos o Latinos , Edad Materna , Adolescente , Estudios de Casos y Controles , Niño , Femenino , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Masculino , Vigilancia de la Población , Factores de Riesgo , Estados Unidos/epidemiología , Adulto JovenRESUMEN
Targeted knockout of genes in primary human cells using CRISPR-Cas9-mediated genome-editing represents a powerful approach to study gene function and to discern molecular mechanisms underlying complex human diseases. We used lentiviral delivery of CRISPR-Cas9 machinery and conditional reprogramming culture methods to knockout the MUC18 gene in human primary nasal airway epithelial cells (AECs). Massively parallel sequencing technology was used to confirm that the genome of essentially all cells in the edited AEC populations contained coding region insertions and deletions (indels). Correspondingly, we found mRNA expression of MUC18 was greatly reduced and protein expression was absent. Characterization of MUC18 knockout cell populations stimulated with TLR2, 3 and 4 agonists revealed that IL-8 (a proinflammatory chemokine) responses of AECs were greatly reduced in the absence of functional MUC18 protein. Our results show the feasibility of CRISPR-Cas9-mediated gene knockouts in AEC culture (both submerged and polarized), and suggest a proinflammatory role for MUC18 in airway epithelial response to bacterial and viral stimuli.
Asunto(s)
Vectores Genéticos , Lentivirus , Mucosa Respiratoria/metabolismo , Antígeno CD146/genética , Antígeno CD146/inmunología , Antígeno CD146/metabolismo , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Expresión Génica , Técnicas de Inactivación de Genes , Humanos , Inflamación/genética , Cultivo Primario de Células , Mucosa Respiratoria/inmunologíaRESUMEN
Inhaled short-acting beta-agonist (SABA) medication is commonly used in asthma patients to rapidly reverse airway obstruction and improve acute symptoms. We performed a genome-wide association study of SABA medication response using gene-based association tests. A linear mixed model approach was first used for single-nucleotide polymorphism associations, and the results were later combined using GATES to generate gene-based associations. Our results identified SPATA13-AS1 as being significantly associated with SABA bronchodilator response in 328 healthy African Americans. In replication, this gene was associated with SABA response among the two separate groups of African Americans with asthma (n=1073, P=0.011 and n=1968, P=0.014), 149 healthy African Americans (P=0.003) and 556 European Americans with asthma (P=0.041). SPATA13-AS1 was also associated with longitudinal SABA medication usage in the two separate groups of African Americans with asthma (n=658, P=0.047 and n=1968, P=0.025). Future studies are needed to delineate the precise mechanism by which SPATA13-AS1 may influence SABA response.
Asunto(s)
Agonistas Adrenérgicos beta/administración & dosificación , Asma/tratamiento farmacológico , Estudio de Asociación del Genoma Completo , Factores de Intercambio de Guanina Nucleótido/genética , Farmacogenética , Polimorfismo de Nucleótido Simple , Administración por Inhalación , Adulto , Negro o Afroamericano , Asma/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Grupos de PoblaciónRESUMEN
Two primary chitinases have been identified in humans--acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1). Mammalian chitinases have been observed to affect the host's immune response. The aim of this study was to test for association between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD). Polymorphisms in the chitinase genes were selected based on previous associations with respiratory diseases. Polymorphisms that were associated with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for association with COPD affection status in four other COPD case-control populations. Chitinase activity and protein levels were also related to genotypes. In the caucasian LHS population, the baseline forced expiratory volume in one second (FEV(1)) was significantly different between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism. Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes. For CHIT1 rs2494303, a significant association was observed between rate of decline in FEV(1) and the different genotypes. In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were associated with rate of decline in FEV(1). Although a significant effect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the associations with COPD affection status in the other COPD study groups.
Asunto(s)
Quitinasas/genética , Volumen Espiratorio Forzado , Polimorfismo de Nucleótido Simple , Enfermedad Pulmonar Obstructiva Crónica/genética , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Anciano , Líquido del Lavado Bronquioalveolar/química , Estudios de Casos y Controles , Quitinasas/metabolismo , Femenino , Variación Genética , Genotipo , Humanos , Pulmón/metabolismo , Pulmón/fisiopatología , Masculino , Persona de Mediana Edad , Fenotipo , Enfermedad Pulmonar Obstructiva Crónica/enzimología , Fenómenos Fisiológicos Respiratorios , FumarRESUMEN
PURPOSE: To report a series of 3 patients with soft contact lens-related Fusarium keratitis. Two of them were treated with the antiamoebic polyhexamethylene biguanide 0.02% (PHMB) in combination with antifungal drugs, and 1 patient was treated with PHMB as sole antifungal regimen. METHODS: Chart review of 3 patients treated with PHMB in Fusarium keratitis. Two of them were refractory to the commonly used therapy. The antifungal power of PHMB and propamidine isethionate was tested against the patients' isolates as well as against the clinical isolates from another 9 patients with ocular mould infections. RESULTS: An excellent outcome could be achieved in 2 patients with Fusarium solani keratitis refractory to common antifungal treatment by the additional use of PHMB 0.02%. In another patient PHMB alone was sufficient to resolve Fusarium proliferatum infection. The drug was well tolerated. In all patients repeated abrasion was done for better penetration of the drugs. PHMB revealed a marked in vitro antifungal activity for the three Fusarium isolates as well as for another 9 isolates of ocular infections from other patients including also the genera Scedosporium, Aspergillus and Rhizopus giving minimal inhibitory concentrations ranging from 1.56 to 3.12 µg/ml. CONCLUSIONS: Fusarium keratitis is a severe ocular infection. We report on the use of PHMB in 3 patients given additionally or as sole antifungal drug. We emphasize the benefit of PHMB 0.02% in Fusarium keratitis which might be considered as a therapeutic option especially in cases refractory to common antifungal therapy and possibly in keratitis due to other fungi.
Asunto(s)
Antifúngicos/uso terapéutico , Biguanidas/uso terapéutico , Úlcera de la Córnea/tratamiento farmacológico , Desinfectantes/uso terapéutico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Fusariosis/tratamiento farmacológico , Fusarium/aislamiento & purificación , Adulto , Antifúngicos/farmacología , Benzamidinas/farmacología , Benzamidinas/uso terapéutico , Biguanidas/farmacología , Lentes de Contacto Hidrofílicos/microbiología , Úlcera de la Córnea/microbiología , Desinfectantes/farmacología , Quimioterapia Combinada , Infecciones Fúngicas del Ojo/microbiología , Femenino , Hongos/efectos de los fármacos , Fusariosis/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Natamicina/farmacología , Natamicina/uso terapéutico , Pirimidinas/farmacología , Pirimidinas/uso terapéutico , Triazoles/farmacología , Triazoles/uso terapéutico , VoriconazolRESUMEN
BACKGROUND: Leukotrienes play an important role in allergic and inflammatory diseases, but reports on the involvement of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) in asthma have been inconclusive. OBJECTIVE: To determine whether polymorphisms in ALOX5AP and LTA4H genes are risk factors for asthma in two different Latino groups: Mexicans and Puerto Ricans. METHODS: The LTA4H gene was sequenced in individuals from both groups to identify novel polymorphisms. Single-nucleotide polymorphisms (SNPs) in the ALOX5AP and LTA4H genes were analysed for associations with asthma and asthma-related phenotypes in 687 parent-child trios of Mexican and Puerto Rican origin. RESULTS: In LTA4H, five previously unknown polymorphisms were identified. Two SNPs within LTA4H (rs17525488 and rs2540493) were protective for asthma in Latinos (P=0.007 and 0.05, respectively). Among the Mexican patients, LTA4H polymorphisms were associated with baseline lung function and IgE levels. For ALOX5AP, the minor allele at SNP rs10507391 was associated with protection from asthma (odds ratio=0.78, P=0.02) and baseline lung function (P=0.018) in Puerto Ricans. A gene-gene interaction was identified between LTA4H (rs17525488) and ALOX5AP (rs10507391), (P=0.003, in the combined sample). CONCLUSION: Our results support the role of LTA4H and ALOX5AP variants as risk factors for asthma in Latino populations.
Asunto(s)
Asma/genética , Proteínas Portadoras/genética , Epóxido Hidrolasas/genética , Predisposición Genética a la Enfermedad , Hispánicos o Latinos/genética , Proteínas de la Membrana/genética , Proteínas Activadoras de la 5-Lipooxigenasa , Adolescente , Alelos , Asma/etnología , Asma/fisiopatología , Proteínas Portadoras/metabolismo , Niño , Epóxido Hidrolasas/metabolismo , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Humanos , Masculino , Proteínas de la Membrana/metabolismo , Americanos Mexicanos , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Adulto JovenRESUMEN
This report describes an uncommon case of cryptococcosis in an apparently immunocompetent cat caused by Cryptococcus magnus. An amputation of the complete left foreleg and excision of the ipsilateral cervical lymph node were performed in a young-adult male Domestic Shorthair cat due to suspicion of a tumor. Granulomatous dermatitis, panniculitis, myositis, and lymphadenitis were diagnosed histologically. Intralesional, numerous round-to-ovoid yeast cells showing no capsule were detected within macrophages using special staining methods. The tissue material cultured on Sabouraud's glucose agar at 26°C yielded abundant growth of yeast colonies. Morphological, physiological, and molecular analyses of the yeasts demonstrated that the fungus was C. magnus. Response to treatment with fluconazole was fast and effective, and one year after the end of the therapy no further clinical signs of infection were observed.
Asunto(s)
Enfermedades de los Gatos/microbiología , Criptococosis/veterinaria , Cryptococcus/aislamiento & purificación , Animales , Antifúngicos/uso terapéutico , Secuencia de Bases , Enfermedades de los Gatos/tratamiento farmacológico , Enfermedades de los Gatos/patología , Gatos , Criptococosis/tratamiento farmacológico , Criptococosis/microbiología , Criptococosis/patología , Cryptococcus/genética , ADN Intergénico/genética , Fluconazol/uso terapéutico , Masculino , Datos de Secuencia Molecular , ARN de Hongos/genética , ARN Ribosómico/genéticaRESUMEN
Scedosporium prolificans is one of the most life-threatening fungal opportunistic pathogens due to its high resistance to common systemic antifungal agents. While a close relative of Pseudallescheria boydii, S. prolificans has a more limited geographic range being primarily found in Australia, USA and Spain. Infections have also been reported from several other European countries and from Chile. Twenty patients with Scedosporium prolificans infection or colonization from August 1993 to May 2007 were retrospectively reviewed in Germany. They had all been identified at or reported to the Reference Laboratory for Pseudallescheria/Scedosporium spp. in Berlin. Twelve of 13 patients with haematological disorders and/or on immunosuppressive therapy developed a fatal invasive scedosporiosis. Colonization of the respiratory tract was reported for one patient after heart-lung-transplantation, all six patients with cystic fibrosis and one with chronic sinusitis. Molecular studies of the S. prolificans isolates confirmed that parts of the 18S, the Internal Transcribed Spacer (ITS) regions and the D1/D2 domain of the 28S region of rDNA are monomorphic. However, sequencing of parts of the translation elongation factor EF1-alpha (EF-1alpha) and the chitin synthase (CHS-1) genes revealed the presence of three and two distinct genotypes, respectively. Two informative mutations were found in EF-1alpha and a single nucleotide exchange in the CHS-1 gene.
Asunto(s)
Micosis/epidemiología , Micosis/microbiología , Scedosporium/aislamiento & purificación , Adolescente , Adulto , Niño , Quitina Sintasa/genética , ADN de Hongos/química , ADN de Hongos/genética , ADN Ribosómico/química , ADN Ribosómico/genética , ADN Espaciador Ribosómico/química , ADN Espaciador Ribosómico/genética , Femenino , Proteínas Fúngicas/genética , Alemania/epidemiología , Neoplasias Hematológicas/complicaciones , Humanos , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Masculino , Persona de Mediana Edad , Factor 1 de Elongación Peptídica/genética , Filogenia , Polimorfismo Genético , ARN Ribosómico 28S/genética , Análisis de Secuencia de ADN , Adulto JovenRESUMEN
Fusarium infections are associated with high mortality after allogeneic stem cell transplantation. We report on successful treatment of a disseminated cutaneous Fusarium proliferatum infection using liposomal amphotericin B and terbinafine. In vitro susceptibility tests of antifungal drugs suggest that terbinafine is a potent additional antifungal drug for disseminated cutaneous fusariosis.
Asunto(s)
Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Dermatomicosis/tratamiento farmacológico , Naftalenos/uso terapéutico , Trasplante de Células Madre/efectos adversos , Trasplante Homólogo/efectos adversos , Dermatomicosis/microbiología , Quimioterapia Combinada , Femenino , Fusarium/efectos de los fármacos , Humanos , Persona de Mediana Edad , Neutropenia/complicaciones , Terapia Recuperativa , Terbinafina , Resultado del TratamientoRESUMEN
OBJECTIVE: Detection of hyphomycetes of the Scedosporium apiospermum complex and Lomentospora prolificans (Sac-Lp) is not yet standardized. Prevalence rates in patients with cystic fibrosis (CF) and the resistance pattern of these pathogens in Germany are unknown. METHODS: In a one-year prospective study 11 laboratories used a selective medium for isolation of Sac-Lp, examining >11,600 respiratory samples from 2346 patients with CF. Isolates were identified by molecular methods and tested for susceptibility to antifungal drugs. RESULTS: The prevalence of Sac-Lp in patients with CF in Germany varied from 0.0 to 10.5% (mean: 3.1%) among the clinical centres. The benefit of the selective medium SceSel(+) compared to standard media for fungi was documented for >5000 samples. High antifungal resistance was detected in the S. apiospermum complex, and the multiresistance of L. prolificans was confirmed. CONCLUSION: Microbiology laboratories should be aware of these resistant species in patients with CF and consider using a selective medium.
Asunto(s)
Antifúngicos/farmacología , Medios de Cultivo/farmacología , Fibrosis Quística , Micosis , Scedosporium , Adulto , Fibrosis Quística/complicaciones , Fibrosis Quística/epidemiología , Fibrosis Quística/microbiología , Farmacorresistencia Fúngica , Femenino , Alemania/epidemiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana/métodos , Micosis/diagnóstico , Micosis/epidemiología , Micosis/etiología , Micosis/microbiología , Prevalencia , Estudios Prospectivos , Scedosporium/clasificación , Scedosporium/efectos de los fármacos , Scedosporium/aislamiento & purificaciónRESUMEN
Systemic mycosis is among the most feared opportunistic infections in the immunocompromised host. Difficulty and delay in diagnosis and treatment often result in poor outcomes. In this communication a metastatically spreading form of subcutaneous aspergillosis developed in a patient with a history of allogeneic stem cell transplantation for relapsed Hodgkin's lymphoma. Strikingly, necrotizing cutaneous papules or ulcerating lesions were absent. Diagnosis was accomplished after excision of a clinically non-suggestive subcutaneous nodule. Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities. This case report describes a novel form of aspergillosis and underlines the need for an aggressive diagnostic approach in severely immunocompromised patients.
Asunto(s)
Aspergilosis/patología , Desoxicitidina/análogos & derivados , Trasplante de Células Madre Hematopoyéticas , Enfermedad de Hodgkin/complicaciones , Infecciones Oportunistas/patología , Adulto , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Aspergilosis/diagnóstico , Aspergilosis/tratamiento farmacológico , Aspergilosis/etiología , Bleomicina/administración & dosificación , Carmustina/administración & dosificación , Terapia Combinada , Ciclofosfamida/administración & dosificación , Citarabina/administración & dosificación , Dacarbazina/administración & dosificación , Desoxicitidina/administración & dosificación , Dexametasona/administración & dosificación , Doxorrubicina/administración & dosificación , Etopósido/administración & dosificación , Resultado Fatal , Enfermedad de Hodgkin/tratamiento farmacológico , Enfermedad de Hodgkin/radioterapia , Enfermedad de Hodgkin/terapia , Humanos , Huésped Inmunocomprometido , Infecciones por Klebsiella/complicaciones , Infecciones por Klebsiella/tratamiento farmacológico , Klebsiella pneumoniae/aislamiento & purificación , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/etiología , Masculino , Melfalán/administración & dosificación , Recurrencia Local de Neoplasia , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/etiología , Neumonía Bacteriana/complicaciones , Neumonía Bacteriana/tratamiento farmacológico , Neumonía por Pneumocystis/complicaciones , Neumonía por Pneumocystis/tratamiento farmacológico , Prednisona/administración & dosificación , Procarbazina/administración & dosificación , Terapia Recuperativa , Piel , Trasplante Homólogo , Vinblastina/administración & dosificación , Vincristina/administración & dosificación , GemcitabinaRESUMEN
Fungitest is a new commercially available and easy-to-perform breakpoint test system using six antifungal agents. We compared this test with a modified standard method described by the National Committee for Clinical Laboratory Standards (NCCLS). One hundred isolates of Candida species were tested with both methods. Based on the same breakpoints, the correlation of qualitative results between the reference method and Fungitest was high. Best results were obtained after incubation of Fungitest for 48 h. Overall agreement was high, an excellent correlation was given with amphotericin B and flucytosine (100% and 99%, respectively), whereas itraconazole showed only 86% concordance. When Fungitest was read after 24 h the agreement was lower ranging from 100% to 75%. Some of the breakpoints used with Fungitest differ from the breakpoints recommended by NCCLS, whereas others have not been elaborated by the NCCLS. The adaptation of Fungitest breakpoints to NCCLS and determination of further breakpoints have to be discussed before Fungitest can be recommended for routine use.
Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Anfotericina B/farmacología , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Farmacorresistencia Microbiana , Fluconazol/farmacología , Fluconazol/uso terapéutico , Flucitosina/farmacología , Flucitosina/uso terapéutico , Itraconazol/farmacología , Itraconazol/uso terapéutico , Cetoconazol/farmacología , Cetoconazol/uso terapéutico , Miconazol/farmacología , Miconazol/uso terapéutico , Pruebas de Sensibilidad MicrobianaRESUMEN
The clinical course and response to therapy of seven patients with cryptococcosis and AIDS were reviewed. One patient was still in the primary stage of cryptococcosis in AIDS, i.e. the stage that is characterized by the sole cultural detection of Cryptococcus neoformans in the respiratory tract. The other six patients were in the secondary stage, where C. neoformans can be detected from the cerebrospinal fluid (CSF), blood, urine, faeces and other body sites. The main presenting features (headache, fever, nausea) were due to central nervous system involvement, although meningism and mental changes were rarely present, and CSF changes were very subtle. Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases. Adverse reactions to the drugs used occurred frequently and consisted mainly of anaemia, hepatosis and fever. Diagnosis in the primary stage of cryptococcosis may improve the prognosis.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Criptococosis/complicaciones , Enfermedades del Sistema Nervioso/etiología , Infecciones Oportunistas/complicaciones , Adulto , Anfotericina B/uso terapéutico , Criptococosis/tratamiento farmacológico , Flucitosina/uso terapéutico , Humanos , Masculino , Infecciones Oportunistas/tratamiento farmacológicoRESUMEN
Right hemisphere brain-damaged (RHD) patients and healthy elderly and younger control subjects were tested on a battery of tasks designed to probe their script knowledge. More specifically, their ability to access and organize script information was assessed under conditions that varied in information-processing demands. For this purpose, two types of script tasks were employed: free response tasks, for which subjects had to structure their own responses, and constrained response tasks, in which subjects had to choose the better of two possible responses. All RHD patients tested had shown impairments on other narrative tasks. Subjects were asked to produce the sequences of steps which comprise two common activities and to provide continuations for segments of scripts (free-response tasks); they also were required to judge script element membership, temporal order, and relative importance (constrained-response tasks). The RHD patients and elderly and control subjects demonstrated a generally preserved knowledge of script information on all tasks. However, because of variability in the response style from the RHD patients and elderly subjects on free-response tasks, individual cases were examined. Several RHD patients' script productions were characterized by tangentiality while other patients showed a tendency to terminate their script productions prematurely. Four of ten elderly subjects produced highly personalized scripts. The relation of performance on these tasks to other documented narrative impairments is considered.
Asunto(s)
Afasia/diagnóstico , Daño Encefálico Crónico/diagnóstico , Dominancia Cerebral , Memoria , Recuerdo Mental , Anciano , Anciano de 80 o más Años , Formación de Concepto , Humanos , Persona de Mediana Edad , Pruebas Neuropsicológicas , Medición de la Producción del Habla , Aprendizaje VerbalRESUMEN
Glycosides of polygalacic acid (2 beta,3 beta,16 alpha,23-tetrahydroxy-olean-12-ene-28-oic acid) is isolated from the aerial parts of Solidago virgaurea L. subsp. virgaurea, Heteropappus altaicus (Willd.) Novopokr. and Heteropappus biennis (Ldb.) Tamamsch. or produced by degradation of these genuine saponins were tested against humanpathogenic strains of Candida albicans, C. glabrata, C. krusei and C. tropicalis using a micro-dilution assay. The antifungal action can be influenced the variation of the etherglycosidically bonded carbohydrate units at C-3 as well as of the acylglycosidically bonded oligosaccharide at C-28 of the aglycone.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Candida albicans/efectos de los fármacos , Glicósidos/farmacología , Ácido Oleanólico/análogos & derivados , Plantas Medicinales/química , Saponinas/farmacología , Triterpenos/farmacología , Antineoplásicos Fitogénicos/química , Glicósidos/química , Hidrólisis , Pruebas de Sensibilidad Microbiana , Saponinas/química , Triterpenos/químicaAsunto(s)
Misiones Médicas , Grupo de Atención al Paciente , Guerra , Heridas y Lesiones/terapia , Afganistán , Niño , Humanos , Masculino , Persona de Mediana Edad , PakistánRESUMEN
Candidal vertebral osteomyelitis represents an extremely rare invasive mycosis and can be difficult to treat due to poor drug penetration into bony tissue. We report on a case of vertebral osteomyelitis caused by Candida krusei in a patient who had neutropenia as a result of chemotherapy for acute myelogenous leukaemia. The patient received prophylactic liposomal amphotericin B during chemotherapy but became febrile and experienced severe lumbar pain. Magnetic resonance imaging revealed vertebral osteochondrosis. C. krusei was recovered from blood cultures and voriconazole monotherapy was initiated but proved unsuccessful. The patient was then started on caspofungin monotherapy, which was discontinued after Candida krusei was no longer recoverable from blood cultures. However, as lumbar pain increased and spinal biopsy confirmed the presence of Candida krusei, caspofungin therapy was resumed. Oral posaconazole was added to the regimen when the patient did not improve after 30 days of caspofungin therapy. Combined antimycotic therapy resulted in a successful outcome.
Asunto(s)
Candida/patogenicidad , Candidiasis/tratamiento farmacológico , Equinocandinas/uso terapéutico , Vértebras Lumbares/microbiología , Triazoles/uso terapéutico , Antifúngicos/uso terapéutico , Candidiasis/diagnóstico , Candidiasis/microbiología , Caspofungina , Quimioterapia Combinada , Humanos , Lipopéptidos , Vértebras Lumbares/patología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Osteomielitis/diagnóstico , Osteomielitis/tratamiento farmacológico , Osteomielitis/microbiologíaRESUMEN
Fungal infections are a major cause of morbidity and mortality in patients during chemotherapeutic treatments and malignant hematologic disease. We present a case of a double fungal infection with disseminated Acremonium strictum (A. strictum) and pulmonary Aspergillus fumigatus (A. fumigatus) and its rapid clinical course. A 17-year-old boy with prolonged neutropenia developed a disseminated fungal infection during induction chemotherapy of his acute lymphoblastic leukemia. The infection was rapidly lethal despite neutrophil recovery and early antifungal combination therapy with amphotericin B and caspofungin. Since there are only a few reports about invasive Acremonium infections, we present this case with regard to differences in the clinic pathologic features of Aspergillosis and other opportunistic fungal infections due to Fusarium or Acremonium species.